Food and Drug Administration

Center for Biologics Evaluation and Research

Cellular, Tissue and Gene Therapies Advisory Committee

Meeting #38

 March 3-4

Quality Suites, Rockville, MD

 

DRAFT AGENDA

 

March 3, 2005

            Open Committee Discussion

Cellular Therapies for Repair and Regeneration of Joint Surfaces

 

8:00 a.m.                     Welcoming Remarks

 

                                    Conflict of Interest Statement

                                               

Introduction of Members

                                    Recognition of Member Committee Service

 

8:30                             FDA Introduction

 

8:40                             Guest Presentation: Evaluating Methods of Restoring Cartilaginous Articular Surfaces

 

9:10                             Guest Presentation: The Biology of the Joint Surface

                                               

9:50                             Break

 

10:00            FDA Perspective on Development of Cartilage Repair Products –Preclinical

 

10:20                           Guest Presentation: Preclinical Models

 

11:00                           Open Public Hearing

 

11:30                           Committee Discussion of Preclinical Questions

12:30 p.m.                   Lunch

1:30                             Committee Discussion of Preclinical Questions (cont’d)

 

2:30                             FDA Perspective on Development of Cartilage Repair Products–Clinical

                                   

2:50                             Guest Presentations:  Clinical Issues

 

4:10                 Break

 

4:25                             FDA Introduction to Clinical Questions

4:30                             Committee Discussion of Clinical Questions      

6:00 p.m.                     Adjourn         


Cellular, Tissue and Gene Therapies Advisory Committee

Meeting #38

March 3-4, 2005

 

DRAFT AGENDA

 

 

March 4, 2005

            Open Committee Discussion

                        Topic I - Cellular Therapies for Repair and Regeneration of Joint Surfaces

                       

8:00 a.m.                     Welcome and Administrative Remarks

                                               

8:05                             Committee Discussion of Clinical Questions (Continued from March 3)

 

8:30                             FDA Perspective on Development of Cartilage Repair Products – Manufacturing

 

8:50                             Committee Discussion of Manufacturing Questions

 

11:00 a.m.                   Adjourn